Latest Epocrates (EPOC) Headlines Europe and No
Post# of 1
Posted On: 03/13/2014 8:07:35 AM
Latest Epocrates (EPOC) Headlines
Europe and North America Drive Demand for Premium, Sustainable Lubricants to Meet Environmental Regulations
M2 - Tue Feb 25, 8:20AM CST
Rising vehicle production and manufacturing output accompanied by the enforcement of eco-friendly policies have lent momentum to the global lubricant market. Demand will escalate especially in developing countries such as Brazil, Russia, India and China, with the ASEAN (Association of Southeast Asian Nations), the Middle East, South America and Africa also emerging as potential growth markets. While developing regions will account for volume growth in lubricants, Europe and North America will push for high-efficiency, premium products in response to regulatory implications and customer demands.
Doximity Physician Network Doubled in 2013
Marketwire - Thu Jan 09, 8:00AM CST
Doximity, the largest and fastest-growing secure network for physicians, today shared its record-setting 2013 growth numbers. The network more than doubled in size in the past year to 250,000 members -- outgrowing such esteemed companies and organizations as Epocrates, Epic, and the American Medical Association -- and established itself as the nation's leading medical collaborative.
Doximity Takes on Physician Shortage With Launch of Talent Finder
Marketwire - Thu Dec 12, 8:02AM CST
Doximity, the largest and fastest-growing secure network for physicians with over 220,000 members, today announced the launch of Talent Finder, a service to connect doctors with new careers and consulting opportunities.
WebMD Rides Road to Recovery
Amy Ho, The Motley Fool - Motley Fool - Wed Oct 30, 11:58AM CDT
WebMD recently announced a repurchasing of 5.5 million shares from Carl Icahn and affiliates for a total of $177.3 million, a move that came as the company stabilizes its future outlook.. The leading health portal in the U.S., WebMD provides free...
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Epocrates, Inc.
Business Wire - Wed Mar 13, 6:06PM CDT
Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court, Northern District of California on behalf of all those who purchased common stock of Epocrates, Inc. ("Epocrates" or the "Company") (NASDAQ:EPOC) between February 2, 2011 and August 9, 2011, inclusive (the "Class Period").
Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Epocrates, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the May 7, 2013 Lead Plaintiff Deadline -- EPOC
GlobeNewswire - Tue Mar 12, 11:57AM CDT
Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of: (1) purchasers of the common stock of Epocrates, Inc. ("Epocrates" or the "Company") (Nasdaq:EPOC) in and/or following the Company's initial public offering on or about February 2, 2011, inclusive (the "IPO"); and (2) purchasers of Epocrates common stock during the period between February 2, 2011 and August 9, 2011, inclusive (the "Class Period").
Scott+Scott, Attorneys at Law, LLP Files Securities Class Action Lawsuit Against Epocrates, Inc. -- EPOC
GlobeNewswire - Fri Mar 08, 7:00PM CST
Scott+Scott, Attorneys at Law, LLP filed a class action complaint in the United States District Court for the Northern District of California on behalf of those persons and entities: (1) who purchased or otherwise acquired Epocrates, Inc. ("Epocrates" or the "Company") (Nasdaq:EPOC) securities between February 2, 2011 and August 9, 2011, inclusive (the "Class Period"); and (2) who purchased or otherwise acquired Epocrates securities pursuant and/or traceable to the Company's Registration Statement and Prospectus (collectively, the "Registration Statement") issued in connection with the Company's February 2, 2011 initial public offering (the "IPO" or the "Offering"). The action seeks remedies under the Securities Act of 1933 and the Securities Exchange Act of 1934.
The Zacks Analyst Blog Highlights: Athenahealth, Microsoft, Epocrates, Cerner and Allscripts Healthcare Solutions
PR Newswire - Wed Mar 06, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Athenahealth (Nasdaq:ATHN), Microsoft (Nasdaq:MSFT), Epocrates (Nasdaq:EPOC), Cerner Corporation (Nasdaq:CERN) and Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX).
Athenahealth's New Product - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 05, 2:50PM CST
Athenahealth recently introduced athenaClarity, which is an analytical offering for health care entities.
EPOC, JMBA, GSB Expected To Be Down After Next Earnings Releases
M2 - Mon Mar 04, 6:02AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, March 5th 2013 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and December earnings reports. Epocrates Inc (NASDAQ:EPOC), JAMBA, INC. (NASDAQ:JMBA), GlobalSCAPE Inc (AMEX:GSB) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/str
Epocrates Earnings Are on Deck
Seth Jayson, The Motley Fool - Motley Fool - Mon Feb 25, 12:21AM CST
Epocrates ( NASDAQ: EPOC ) is expected to report Q4 earnings around Feb. 28. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year quarter, average analyst estimates...
Athena's Mixed 4Q; Profit Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 08, 2:40PM CST
Athenahealth's fourth quarter 2012 earnings beat while revenues fall short of the Zacks Consensus Estimate. The company's profits rise on a year-over-year basis.
13 in a Row for athenahealth
Keith Speights, The Motley Fool - Motley Fool - Fri Feb 08, 10:46AM CST
The number 13 stood out for athenahealth CEO Jonathan Bush when discussing his company's earnings announced on Thursday. That's the number of consecutive years that athenahealth grew sales by 30% or more. There were other good numbers...
Epocrates Inc. (EPOC) is Investigated by Faruqi & Faruqi, LLP for Potential Breaches of Fiduciary Duties
Business Wire - Wed Jan 30, 10:43AM CST
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Epocrates, Inc. ("Epocrates" or the "Company") (NASDAQ: EPOC) for potential breaches of fiduciary duties in connection with their duty to disclose material information in the Preliminary Proxy ("Proxy") filed with the Securities and Exchange Commission on January 25, 2013 in relation to the sale of the Company to athenahealth Inc. (NASDAQ: ATHN) in an all-cash deal valued at approximately $293 million. Furthermore, the price per share agreed to in the proposed transaction is also under investigation since Epocrates' stockholders will receive only $11.75 in cash for each share of Epocrates common stock they own, while according to Yahoo! Finance, at least one financial analyst has set a price target of $13 for Epocrates.
Epocrates Helped Physicians Avoid 27 Million Drug Errors in 2012
GlobeNewswire - Wed Jan 23, 8:00AM CST
Patient safety is a top priority for all clinicians, yet preventable drug errors are still prevalent throughout the United States. In the past year, Epocrates (Nasdaq:EPOC) has helped clinicians avoid more than 27 million adverse drug events through its popular medical application. This translates to more than 25 percent of Epocrates drug lookups preventing a minor to serious adverse drug event.
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Epocrates, Inc. in Connection with the Sale of the Company to athenahealth, Inc.
PR Newswire - Thu Jan 17, 5:14PM CST
Levi & Korsinsky notifies investors of Epocrates, Inc. ("Epocrates" or the "Company") (NasdaqGS: EPOC) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to athenahealth, Inc. (Nasdaq: ATHN). A complaint was filed in California state court.
INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating the Acquisition of Epocrates Inc. (EPOC)
Business Wire - Thu Jan 17, 2:39PM CST
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Epocrates, Inc. ("Epocrates" or the "Company") (NASDAQ: EPOC) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to athenahealth Inc. (NASDAQ: ATHN) in an all-cash deal valued at approximately $293 million. Under the terms of the proposed transaction, Epocrates' stockholders will receive $11.75 in cash for each share of Epocrates common stock they own, while according to Yahoo! Finance, at least one financial analyst has set a price target of $13 for Epocrates.
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Epocrates, Inc. in Connection With the Sale of the Company to athenahealth, Inc. -- EPOC
GlobeNewswire - Thu Jan 17, 2:27PM CST
Levi & Korsinsky notifies investors of Epocrates, Inc. ("Epocrates" or the "Company") (Nasdaq:EPOC) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to athenahealth, Inc. A complaint was filed in California state court.
Battle over "Mobile Healthcare"
mthiessen@kingsgateinvestments.ca (Mike Thiessen)via The Motley Fool - Motley Fool - Tue Jan 15, 8:50AM CST
Electronic health record and practice management provider Athenahealth (NASDAQ: ATHN) recently announced its intention to purchase mobile medical-reference and "point-of-care" provider Epocrates (NASDAQ: EPOC) for about $293...
Ryan & Maniskas, LLP Announces Investigation of Epocrates, Inc.
PR Newswire - Fri Jan 11, 5:35PM CST
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/epoc) is investigating potential claims against the board of directors of Epocrates, Inc. ("Epocrates" or the "Company") (NASDAQ: EPOC) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to athenahealth Inc. (ATHN) in an all-cash deal valued at approximately $293 million.
Europe and North America Drive Demand for Premium, Sustainable Lubricants to Meet Environmental Regulations
M2 - Tue Feb 25, 8:20AM CST
Rising vehicle production and manufacturing output accompanied by the enforcement of eco-friendly policies have lent momentum to the global lubricant market. Demand will escalate especially in developing countries such as Brazil, Russia, India and China, with the ASEAN (Association of Southeast Asian Nations), the Middle East, South America and Africa also emerging as potential growth markets. While developing regions will account for volume growth in lubricants, Europe and North America will push for high-efficiency, premium products in response to regulatory implications and customer demands.
Doximity Physician Network Doubled in 2013
Marketwire - Thu Jan 09, 8:00AM CST
Doximity, the largest and fastest-growing secure network for physicians, today shared its record-setting 2013 growth numbers. The network more than doubled in size in the past year to 250,000 members -- outgrowing such esteemed companies and organizations as Epocrates, Epic, and the American Medical Association -- and established itself as the nation's leading medical collaborative.
Doximity Takes on Physician Shortage With Launch of Talent Finder
Marketwire - Thu Dec 12, 8:02AM CST
Doximity, the largest and fastest-growing secure network for physicians with over 220,000 members, today announced the launch of Talent Finder, a service to connect doctors with new careers and consulting opportunities.
WebMD Rides Road to Recovery
Amy Ho, The Motley Fool - Motley Fool - Wed Oct 30, 11:58AM CDT
WebMD recently announced a repurchasing of 5.5 million shares from Carl Icahn and affiliates for a total of $177.3 million, a move that came as the company stabilizes its future outlook.. The leading health portal in the U.S., WebMD provides free...
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Epocrates, Inc.
Business Wire - Wed Mar 13, 6:06PM CDT
Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court, Northern District of California on behalf of all those who purchased common stock of Epocrates, Inc. ("Epocrates" or the "Company") (NASDAQ:EPOC) between February 2, 2011 and August 9, 2011, inclusive (the "Class Period").
Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Epocrates, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the May 7, 2013 Lead Plaintiff Deadline -- EPOC
GlobeNewswire - Tue Mar 12, 11:57AM CDT
Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of: (1) purchasers of the common stock of Epocrates, Inc. ("Epocrates" or the "Company") (Nasdaq:EPOC) in and/or following the Company's initial public offering on or about February 2, 2011, inclusive (the "IPO"); and (2) purchasers of Epocrates common stock during the period between February 2, 2011 and August 9, 2011, inclusive (the "Class Period").
Scott+Scott, Attorneys at Law, LLP Files Securities Class Action Lawsuit Against Epocrates, Inc. -- EPOC
GlobeNewswire - Fri Mar 08, 7:00PM CST
Scott+Scott, Attorneys at Law, LLP filed a class action complaint in the United States District Court for the Northern District of California on behalf of those persons and entities: (1) who purchased or otherwise acquired Epocrates, Inc. ("Epocrates" or the "Company") (Nasdaq:EPOC) securities between February 2, 2011 and August 9, 2011, inclusive (the "Class Period"); and (2) who purchased or otherwise acquired Epocrates securities pursuant and/or traceable to the Company's Registration Statement and Prospectus (collectively, the "Registration Statement") issued in connection with the Company's February 2, 2011 initial public offering (the "IPO" or the "Offering"). The action seeks remedies under the Securities Act of 1933 and the Securities Exchange Act of 1934.
The Zacks Analyst Blog Highlights: Athenahealth, Microsoft, Epocrates, Cerner and Allscripts Healthcare Solutions
PR Newswire - Wed Mar 06, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Athenahealth (Nasdaq:ATHN), Microsoft (Nasdaq:MSFT), Epocrates (Nasdaq:EPOC), Cerner Corporation (Nasdaq:CERN) and Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX).
Athenahealth's New Product - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 05, 2:50PM CST
Athenahealth recently introduced athenaClarity, which is an analytical offering for health care entities.
EPOC, JMBA, GSB Expected To Be Down After Next Earnings Releases
M2 - Mon Mar 04, 6:02AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, March 5th 2013 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and December earnings reports. Epocrates Inc (NASDAQ:EPOC), JAMBA, INC. (NASDAQ:JMBA), GlobalSCAPE Inc (AMEX:GSB) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/str
Epocrates Earnings Are on Deck
Seth Jayson, The Motley Fool - Motley Fool - Mon Feb 25, 12:21AM CST
Epocrates ( NASDAQ: EPOC ) is expected to report Q4 earnings around Feb. 28. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year quarter, average analyst estimates...
Athena's Mixed 4Q; Profit Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 08, 2:40PM CST
Athenahealth's fourth quarter 2012 earnings beat while revenues fall short of the Zacks Consensus Estimate. The company's profits rise on a year-over-year basis.
13 in a Row for athenahealth
Keith Speights, The Motley Fool - Motley Fool - Fri Feb 08, 10:46AM CST
The number 13 stood out for athenahealth CEO Jonathan Bush when discussing his company's earnings announced on Thursday. That's the number of consecutive years that athenahealth grew sales by 30% or more. There were other good numbers...
Epocrates Inc. (EPOC) is Investigated by Faruqi & Faruqi, LLP for Potential Breaches of Fiduciary Duties
Business Wire - Wed Jan 30, 10:43AM CST
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Epocrates, Inc. ("Epocrates" or the "Company") (NASDAQ: EPOC) for potential breaches of fiduciary duties in connection with their duty to disclose material information in the Preliminary Proxy ("Proxy") filed with the Securities and Exchange Commission on January 25, 2013 in relation to the sale of the Company to athenahealth Inc. (NASDAQ: ATHN) in an all-cash deal valued at approximately $293 million. Furthermore, the price per share agreed to in the proposed transaction is also under investigation since Epocrates' stockholders will receive only $11.75 in cash for each share of Epocrates common stock they own, while according to Yahoo! Finance, at least one financial analyst has set a price target of $13 for Epocrates.
Epocrates Helped Physicians Avoid 27 Million Drug Errors in 2012
GlobeNewswire - Wed Jan 23, 8:00AM CST
Patient safety is a top priority for all clinicians, yet preventable drug errors are still prevalent throughout the United States. In the past year, Epocrates (Nasdaq:EPOC) has helped clinicians avoid more than 27 million adverse drug events through its popular medical application. This translates to more than 25 percent of Epocrates drug lookups preventing a minor to serious adverse drug event.
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Epocrates, Inc. in Connection with the Sale of the Company to athenahealth, Inc.
PR Newswire - Thu Jan 17, 5:14PM CST
Levi & Korsinsky notifies investors of Epocrates, Inc. ("Epocrates" or the "Company") (NasdaqGS: EPOC) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to athenahealth, Inc. (Nasdaq: ATHN). A complaint was filed in California state court.
INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating the Acquisition of Epocrates Inc. (EPOC)
Business Wire - Thu Jan 17, 2:39PM CST
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Epocrates, Inc. ("Epocrates" or the "Company") (NASDAQ: EPOC) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to athenahealth Inc. (NASDAQ: ATHN) in an all-cash deal valued at approximately $293 million. Under the terms of the proposed transaction, Epocrates' stockholders will receive $11.75 in cash for each share of Epocrates common stock they own, while according to Yahoo! Finance, at least one financial analyst has set a price target of $13 for Epocrates.
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Epocrates, Inc. in Connection With the Sale of the Company to athenahealth, Inc. -- EPOC
GlobeNewswire - Thu Jan 17, 2:27PM CST
Levi & Korsinsky notifies investors of Epocrates, Inc. ("Epocrates" or the "Company") (Nasdaq:EPOC) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to athenahealth, Inc. A complaint was filed in California state court.
Battle over "Mobile Healthcare"
mthiessen@kingsgateinvestments.ca (Mike Thiessen)via The Motley Fool - Motley Fool - Tue Jan 15, 8:50AM CST
Electronic health record and practice management provider Athenahealth (NASDAQ: ATHN) recently announced its intention to purchase mobile medical-reference and "point-of-care" provider Epocrates (NASDAQ: EPOC) for about $293...
Ryan & Maniskas, LLP Announces Investigation of Epocrates, Inc.
PR Newswire - Fri Jan 11, 5:35PM CST
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/epoc) is investigating potential claims against the board of directors of Epocrates, Inc. ("Epocrates" or the "Company") (NASDAQ: EPOC) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to athenahealth Inc. (ATHN) in an all-cash deal valued at approximately $293 million.
(0)
(0)Epocrates (EPOC) Stock Research Links
Scroll down for more posts ▼